509 related articles for article (PubMed ID: 36091114)
1. Neutrophils: Musketeers against immunotherapy.
Zahid KR; Raza U; Tumbath S; Jiang L; Xu W; Huang X
Front Oncol; 2022; 12():975981. PubMed ID: 36091114
[TBL] [Abstract][Full Text] [Related]
2. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
Zhang Y; Guoqiang L; Sun M; Lu X
Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
[TBL] [Abstract][Full Text] [Related]
3. IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy.
Teijeira A; Garasa S; Ochoa MC; Villalba M; Olivera I; Cirella A; Eguren-Santamaria I; Berraondo P; Schalper KA; de Andrea CE; Sanmamed MF; Melero I
Clin Cancer Res; 2021 May; 27(9):2383-2393. PubMed ID: 33376096
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular traps in tumor progression and immunotherapy.
Yan M; Gu Y; Sun H; Ge Q
Front Immunol; 2023; 14():1135086. PubMed ID: 36993957
[TBL] [Abstract][Full Text] [Related]
5. Rational targeting of immunosuppressive neutrophils in cancer.
Zhao Y; Rahmy S; Liu Z; Zhang C; Lu X
Pharmacol Ther; 2020 Aug; 212():107556. PubMed ID: 32343986
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils in the era of immune checkpoint blockade.
Faget J; Peters S; Quantin X; Meylan E; Bonnefoy N
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34301813
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil Heterogeneity in Cancer: From Biology to Therapies.
Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC
Front Immunol; 2019; 10():2155. PubMed ID: 31616408
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil Extracellular Traps and Cancer: Trapping Our Attention with Their Involvement in Ovarian Cancer.
Castaño M; Tomás-Pérez S; González-Cantó E; Aghababyan C; Mascarós-Martínez A; Santonja N; Herreros-Pomares A; Oto J; Medina P; Götte M; Mc Cormack BA; Marí-Alexandre J; Gilabert-Estellés J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983067
[TBL] [Abstract][Full Text] [Related]
9. Good cops turn bad: The contribution of neutrophils to immune-checkpoint inhibitor treatment failures in cancer.
Zhang H; Houghton AM
Pharmacol Ther; 2021 Jan; 217():107662. PubMed ID: 32805297
[TBL] [Abstract][Full Text] [Related]
10. Resistance to Checkpoint Inhibition in Cancer Immunotherapy.
Barrueto L; Caminero F; Cash L; Makris C; Lamichhane P; Deshmukh RR
Transl Oncol; 2020 Mar; 13(3):100738. PubMed ID: 32114384
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.
Masucci MT; Minopoli M; Del Vecchio S; Carriero MV
Front Immunol; 2020; 11():1749. PubMed ID: 33042107
[TBL] [Abstract][Full Text] [Related]
12. Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy.
Amir Taghavi B; Alizadeh N; Saeedi H; Karim Ahangar N; Derakhshani A; Hajiasgharzadeh K; Silvestris N; Baradaran B; Brunetti O
Molecules; 2022 May; 27(11):. PubMed ID: 35684481
[TBL] [Abstract][Full Text] [Related]
13. No NETs no TIME: Crosstalk between neutrophil extracellular traps and the tumor immune microenvironment.
Fang Q; Stehr AM; Naschberger E; Knopf J; Herrmann M; Stürzl M
Front Immunol; 2022; 13():1075260. PubMed ID: 36618417
[TBL] [Abstract][Full Text] [Related]
14. Blockade of neutrophil recruitment to tumor sites based on sialic acid-modified nanoplatforms enhances the efficacy of checkpoint blockade immunotherapy.
Chen M; Qi Z; Meng X; Wang S; Zheng X; Hu M; Liu X; Song Y; Deng Y
Asian J Pharm Sci; 2023 Mar; 18(2):100784. PubMed ID: 36968653
[TBL] [Abstract][Full Text] [Related]
15. Influence of Interleukin-8 and Neutrophil Extracellular Trap (NET) Formation in the Tumor Microenvironment: Is There a Pathogenic Role?
Gonzalez-Aparicio M; Alfaro C
J Immunol Res; 2019; 2019():6252138. PubMed ID: 31093511
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression in Human Polymorphonuclear Neutrophils (PMNs) Stimulated by Bacillus Calmette-Guérin (BCG).
Liu K; Sun E; Wang L; Nian X; Ma C
Inflammation; 2020 Dec; 43(6):2098-2108. PubMed ID: 32578048
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil diversity and plasticity in tumour progression and therapy.
Jaillon S; Ponzetta A; Di Mitri D; Santoni A; Bonecchi R; Mantovani A
Nat Rev Cancer; 2020 Sep; 20(9):485-503. PubMed ID: 32694624
[TBL] [Abstract][Full Text] [Related]
18. Neutrophils in the Tumor Microenvironment.
Wu L; Saxena S; Singh RK
Adv Exp Med Biol; 2020; 1224():1-20. PubMed ID: 32036601
[TBL] [Abstract][Full Text] [Related]
19. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
20. Resistance mechanisms to immune checkpoints blockade by monoclonal antibody drugs in cancer immunotherapy: Focus on myeloma.
Isazadeh A; Hajazimian S; Garshasbi H; Shadman B; Baghbanzadeh A; Chavoshi R; Taefehshokr S; Farhoudi Sefidan Jadid M; Hajiasgharzadeh K; Baradaran B
J Cell Physiol; 2021 Feb; 236(2):791-805. PubMed ID: 32592235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
